Pedplot

Trulicity plotter

Half-life estimate, not bloodwork or dosing advice. Disclaimer.

t½ 5dTmax 2d100% parent

The prefilled numbers are an example input to draw the curve, not a dose; Pedplot does not suggest one. To step a dose up, add another row of the same compound with a later start day.

Peaks, troughs, and half-life
Not a blood level. The chart shows the estimated milligrams of the drug still in the body, so it will not match a lab result in ng/dL. How the model works. Washout continues after the last dose. Mixed IU and mg protocols are not summed.

Dulaglutide

Peak

1.21 mg

Trough

0.603 mg

Swing

50%

~Steady state

28d

~Washout

27.5d

Saved locally
Stored in localStorage on this device. Reload a saved protocol from this list.

No saved protocols in this browser yet.

Trulicity. Weekly GLP-1 with a half-life in the same range as tirzepatide. There is no ester, so the line is the dose itself. Also called Dulaglutide.

Half-life5d
Time to peak2d
Parent hormone100%
Example input0.75 mg
Example frequencyonce a week
Example length8 weeks
Data qualityHigh

Trulicity label: half-life ~5 days; median Tmax 48 h. How the model works.

The example curve

0.75 mg once a week for 8 weeks. With a 5d half-life, it levels off around day 28. The row runs longer than that, so the plateau is on the chart. Between doses it runs from about 0.603 to 1.21 mg, a swing of 50%. Each dose is its own spike. After the last dose, the tail takes about 27.5 days to fall to a few percent.

Ozempic2 days longer (7d vs 5d).

Sources

  1. FDA label. Trulicity FDA label, 12.3 Pharmacokinetics: elimination half-life approximately 5 days; median Tmax 48 hours (24 to 72)